Home › Obesity › Texas › Corpus Christi
Obesity clinical trials in Corpus Christi, TX
6 studies for Obesity are looking for participants at sites in and around Corpus Christi (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
RecruitingPhase 3
- Osvaldo A. Brusco MD, Corpus Christi
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RecruitingPhase 3
- Driscoll Children's Hospital, Corpus Christi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RecruitingPhase 3
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- South Texas Clinical Research, Corpus Christi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
RecruitingPhase 3
- Osvaldo A Brusco MD PA, Corpus Christi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- South Texas Clinical Research, Corpus Christi
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX43 studies
- Chicago, IL41 studies
- New York City, NY40 studies
- San Antonio, TX40 studies
- Washington, DC33 studies
- Orlando, FL31 studies
- Dallas, TX30 studies
- Boston, MA28 studies
- Las Vegas, NV27 studies
- Miami, FL27 studies
- Baltimore, MD25 studies
- Jacksonville, FL25 studies
Other studies in Corpus Christi
- Overweight5 studies
- Burkitt Lymphoma4 studies
- Type 2 Diabetes4 studies
- Steatotic Liver Disease3 studies
- Acute Biphenotypic Leukemia3 studies
- Acute Myeloid Leukemia3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.